MONALEESA-3 Expands Endocrine Therapy Options for Advanced Breast Cancer - Medscape

Medscape
MONALEESA-3 Expands Endocrine Therapy Options for Advanced Breast Cancer
Medscape
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3. Slamon DJ, Neven P, Chia S, et al. J Clin Oncol. 2018;36:2465-2472 ...